Owner Bioprojet

Inventors Capet, Marc; Robert, Philippe; Levoin, Nicolas; Schwartz, Jean-Charles; Bertrand, Isabelle; Labeeuw, Olivier; Lecomte, Jeanne-Marie; Ligneau, Xavier; Poupardin-Olivier, Olivia

Agent Davies Collison Cave

Pub. Number AU-A-2006242950

PCT Pub. Number WO2006/117609

Priority 05290950.4 29.04.05 EP; 60/678,243 06.05.05 US; 05291793.7 26.08.05 EP

Filing date 25 April 2006

Wipo publication date 9 November 2006

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/5377 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 211/14 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/68 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 295/088 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 333/16 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings